Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,628
archived clinical trials in
Schizophrenia

D-Cycloserine Augmentation of Cognitive Behavioral Therapy for Delusions
D-Cycloserine Augmentation of Cognitive Behavioral Therapy for Delusions
Status: Enrolling
Updated:  12/31/1969
Sheppard Pratt
342
mi
from 43215
Baltimore, MD
D-Cycloserine Augmentation of Cognitive Behavioral Therapy for Delusions
D-Cycloserine Augmentation of Cognitive Behavioral Therapy for Delusions
Status: Enrolling
Updated: 12/31/1969
Sheppard Pratt
342
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
D-Cycloserine Augmentation of Cognitive Behavioral Therapy for Delusions
D-Cycloserine Augmentation of Cognitive Behavioral Therapy for Delusions
Status: Enrolling
Updated:  12/31/1969
New York Langone Medical Center/Bellevue Hospital
479
mi
from 43215
New York, NY
D-Cycloserine Augmentation of Cognitive Behavioral Therapy for Delusions
D-Cycloserine Augmentation of Cognitive Behavioral Therapy for Delusions
Status: Enrolling
Updated: 12/31/1969
New York Langone Medical Center/Bellevue Hospital
479
mi
from 43215
New York, NY
Click here to add this to my saved trials
Cognitive Remediation of Schizophrenia in a Community Mental Health Setting
Cognitive Remediation of Schizophrenia in a Community Mental Health Setting
Status: Enrolling
Updated:  12/31/1969
vinogradov research lab SFVAMC
2108
mi
from 43215
San Francisco, CA
Cognitive Remediation of Schizophrenia in a Community Mental Health Setting
Cognitive Remediation of Schizophrenia in a Community Mental Health Setting
Status: Enrolling
Updated: 12/31/1969
vinogradov research lab SFVAMC
2108
mi
from 43215
San Francisco, CA
Click here to add this to my saved trials
Get Moving and Get Well - Pilot Study
Get Moving and Get Well: A Behavioral Activation Program for Veterans With SMI
Status: Enrolling
Updated:  12/31/1969
Central Arkansas Veterans Healthcare System Eugene J. Towbin Healthcare Center, Little Rock, AR
622
mi
from 43215
North Little Rock, AR
Get Moving and Get Well - Pilot Study
Get Moving and Get Well: A Behavioral Activation Program for Veterans With SMI
Status: Enrolling
Updated: 12/31/1969
Central Arkansas Veterans Healthcare System Eugene J. Towbin Healthcare Center, Little Rock, AR
622
mi
from 43215
North Little Rock, AR
Click here to add this to my saved trials
Building Employment Skills Through Therapy for Veterans
Integrated Cognitive Behavior Therapy to Improve Work Outcomes in Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA
414
mi
from 43215
Philadelphia, PA
Building Employment Skills Through Therapy for Veterans
Integrated Cognitive Behavior Therapy to Improve Work Outcomes in Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA
414
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
Status: Enrolling
Updated:  12/31/1969
C.I. Trials, Inc.-Los Angeles County
1970
mi
from 43215
Bellflower, CA
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
Status: Enrolling
Updated: 12/31/1969
C.I. Trials, Inc.-Los Angeles County
1970
mi
from 43215
Bellflower, CA
Click here to add this to my saved trials
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
Status: Enrolling
Updated:  12/31/1969
University of California at Los Angeles
1982
mi
from 43215
Los Angeles, CA
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
Status: Enrolling
Updated: 12/31/1969
University of California at Los Angeles
1982
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
Status: Enrolling
Updated:  12/31/1969
University of California, Riverside at C.I. Trials, Inc.-Inland Empire
1929
mi
from 43215
Riverside, CA
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
Status: Enrolling
Updated: 12/31/1969
University of California, Riverside at C.I. Trials, Inc.-Inland Empire
1929
mi
from 43215
Riverside, CA
Click here to add this to my saved trials
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
Status: Enrolling
Updated:  12/31/1969
C.I. Trials, Inc.-Orange County
1960
mi
from 43215
Santa Ana, CA
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
Status: Enrolling
Updated: 12/31/1969
C.I. Trials, Inc.-Orange County
1960
mi
from 43215
Santa Ana, CA
Click here to add this to my saved trials
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Yale University
537
mi
from 43215
New Haven, CT
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Yale University
537
mi
from 43215
New Haven, CT
Click here to add this to my saved trials
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Innovative Clinical Research, Inc
965
mi
from 43215
Lauderhill, FL
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Innovative Clinical Research, Inc
965
mi
from 43215
Lauderhill, FL
Click here to add this to my saved trials
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Prevention and Recovery Center for Early Psychosis
167
mi
from 43215
Indianapolis, IN
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Prevention and Recovery Center for Early Psychosis
167
mi
from 43215
Indianapolis, IN
Click here to add this to my saved trials
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Indiana University Psychotic Disorders Clinic
166
mi
from 43215
Indianapolis, IN
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Indiana University Psychotic Disorders Clinic
166
mi
from 43215
Indianapolis, IN
Click here to add this to my saved trials
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Maryland Psychiatric Research Center
337
mi
from 43215
Baltimore, MD
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Maryland Psychiatric Research Center
337
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Centers for Behavioral Health, LLC
318
mi
from 43215
Rockville, MD
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Centers for Behavioral Health, LLC
318
mi
from 43215
Rockville, MD
Click here to add this to my saved trials
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Sheppard Pratt Health System
341
mi
from 43215
Towson, MD
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Sheppard Pratt Health System
341
mi
from 43215
Towson, MD
Click here to add this to my saved trials
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Laureate Institute for Brain Research
752
mi
from 43215
Tulsa, OK
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Laureate Institute for Brain Research
752
mi
from 43215
Tulsa, OK
Click here to add this to my saved trials
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
Status: Enrolling
Updated:  12/31/1969
University of Kansas Medical Center-Witchita
784
mi
from 43215
Wichita, KA
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
Status: Enrolling
Updated: 12/31/1969
University of Kansas Medical Center-Witchita
784
mi
from 43215
Wichita, KA
Click here to add this to my saved trials
Project Bridge: Peer Health Navigator Intervention
A Randomized Controlled Trial of "The Bridge", a Peer Health Navigation Intervention
Status: Enrolling
Updated:  12/31/1969
Pacific Clinics El Camino
1965
mi
from 43215
Santa Fe Springs, CA
Project Bridge: Peer Health Navigator Intervention
A Randomized Controlled Trial of "The Bridge", a Peer Health Navigation Intervention
Status: Enrolling
Updated: 12/31/1969
Pacific Clinics El Camino
1965
mi
from 43215
Santa Fe Springs, CA
Click here to add this to my saved trials
Comparison of E-health vs. In-person MFG
Comparison of E-Health vs. In-Person Delivered Family Psychoeducation Treatment
Status: Enrolling
Updated:  12/31/1969
VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA
161
mi
from 43215
Pittsburgh, PA
Comparison of E-health vs. In-person MFG
Comparison of E-Health vs. In-Person Delivered Family Psychoeducation Treatment
Status: Enrolling
Updated: 12/31/1969
VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA
161
mi
from 43215
Pittsburgh, PA
Click here to add this to my saved trials
Glutamate, Brain Connectivity and Duration of Untreated Psychosis
Glutamate, Brain Connectivity and Duration of Untreated Psychosis
Status: Enrolling
Updated:  12/31/1969
Sparks Center
491
mi
from 43215
Birmingham, AL
Glutamate, Brain Connectivity and Duration of Untreated Psychosis
Glutamate, Brain Connectivity and Duration of Untreated Psychosis
Status: Enrolling
Updated: 12/31/1969
Sparks Center
491
mi
from 43215
Birmingham, AL
Click here to add this to my saved trials
Tocilizumab as Add-On Treatment For Residual Positive, Negative, and Cognitive Symptoms of Schizophrenia
Tocilizumab, An IL-6 Receptor Antibody, As Add-On Treatment For Residual Positive, Negative, and Cognitive Symptoms of Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Status: Enrolling
Updated:  12/31/1969
New York State Psychiatric Institute
481
mi
from 43215
New York, NY
Tocilizumab as Add-On Treatment For Residual Positive, Negative, and Cognitive Symptoms of Schizophrenia
Tocilizumab, An IL-6 Receptor Antibody, As Add-On Treatment For Residual Positive, Negative, and Cognitive Symptoms of Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Status: Enrolling
Updated: 12/31/1969
New York State Psychiatric Institute
481
mi
from 43215
New York, NY
Click here to add this to my saved trials
Randomized Controlled Trial (RCT) of a Motivational Decision Support System
RCT of a Motivational Decision Support System for Smokers With Severe Mental Illnesses
Status: Enrolling
Updated:  12/31/1969
Thresholds
274
mi
from 43215
Chicago, IL
Randomized Controlled Trial (RCT) of a Motivational Decision Support System
RCT of a Motivational Decision Support System for Smokers With Severe Mental Illnesses
Status: Enrolling
Updated: 12/31/1969
Thresholds
274
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
Randomized Controlled Trial (RCT) of a Motivational Decision Support System
RCT of a Motivational Decision Support System for Smokers With Severe Mental Illnesses
Status: Enrolling
Updated:  12/31/1969
Rutgers-UNDMJ
453
mi
from 43215
New Brunswick, NJ
Randomized Controlled Trial (RCT) of a Motivational Decision Support System
RCT of a Motivational Decision Support System for Smokers With Severe Mental Illnesses
Status: Enrolling
Updated: 12/31/1969
Rutgers-UNDMJ
453
mi
from 43215
New Brunswick, NJ
Click here to add this to my saved trials
Randomized Controlled Trial (RCT) of a Motivational Decision Support System
RCT of a Motivational Decision Support System for Smokers With Severe Mental Illnesses
Status: Enrolling
Updated:  12/31/1969
University of Massachusetts
607
mi
from 43215
Worcester, MA
Randomized Controlled Trial (RCT) of a Motivational Decision Support System
RCT of a Motivational Decision Support System for Smokers With Severe Mental Illnesses
Status: Enrolling
Updated: 12/31/1969
University of Massachusetts
607
mi
from 43215
Worcester, MA
Click here to add this to my saved trials
Optimizing Cognitive Remediation Outcomes in Schizophrenia
Optimizing Cognitive Remediation Outcomes in Schizophrenia
Status: Enrolling
Updated:  12/31/1969
San Francisco Veterans Medical Center
mi
from 43215
San Francisco, CA
Optimizing Cognitive Remediation Outcomes in Schizophrenia
Optimizing Cognitive Remediation Outcomes in Schizophrenia
Status: Enrolling
Updated: 12/31/1969
San Francisco Veterans Medical Center
mi
from 43215
San Francisco, CA
Click here to add this to my saved trials
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated:  12/31/1969
Alexian Brothers Behavioral Health Hospital
302
mi
from 43215
Hoffman Estates, IL
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated: 12/31/1969
Alexian Brothers Behavioral Health Hospital
302
mi
from 43215
Hoffman Estates, IL
Click here to add this to my saved trials
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated:  12/31/1969
Altea Research Institute
1759
mi
from 43215
Las Vegas, NV
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated: 12/31/1969
Altea Research Institute
1759
mi
from 43215
Las Vegas, NV
Click here to add this to my saved trials
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated:  12/31/1969
Apostle Clinical Trials, Inc
1977
mi
from 43215
Long Beach, CA
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated: 12/31/1969
Apostle Clinical Trials, Inc
1977
mi
from 43215
Long Beach, CA
Click here to add this to my saved trials
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated:  12/31/1969
Behavioral Clinical Research, Inc.
977
mi
from 43215
North Miami, FL
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated: 12/31/1969
Behavioral Clinical Research, Inc.
977
mi
from 43215
North Miami, FL
Click here to add this to my saved trials
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated:  12/31/1969
Behavioral Research Specialists, LLC
1970
mi
from 43215
Glendale, CA
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated: 12/31/1969
Behavioral Research Specialists, LLC
1970
mi
from 43215
Glendale, CA
Click here to add this to my saved trials
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated:  12/31/1969
CNRI - San Diego, LLC
1949
mi
from 43215
San Diego, CA
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated: 12/31/1969
CNRI - San Diego, LLC
1949
mi
from 43215
San Diego, CA
Click here to add this to my saved trials
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated:  12/31/1969
CNRI - Los Angeles LLC
1965
mi
from 43215
Pico Rivera, CA
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated: 12/31/1969
CNRI - Los Angeles LLC
1965
mi
from 43215
Pico Rivera, CA
Click here to add this to my saved trials
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated:  12/31/1969
Community Clinical Research
1057
mi
from 43215
Austin, TX
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated: 12/31/1969
Community Clinical Research
1057
mi
from 43215
Austin, TX
Click here to add this to my saved trials
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated:  12/31/1969
Comprehensive Clinical Development - Cerritos, CA
1967
mi
from 43215
Cerritos, CA
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated: 12/31/1969
Comprehensive Clinical Development - Cerritos, CA
1967
mi
from 43215
Cerritos, CA
Click here to add this to my saved trials
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated:  12/31/1969
CRI Lifetree
416
mi
from 43215
Philadelphia, PA
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated: 12/31/1969
CRI Lifetree
416
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated:  12/31/1969
Excell Research, Inc.
1944
mi
from 43215
Oceanside, CA
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated: 12/31/1969
Excell Research, Inc.
1944
mi
from 43215
Oceanside, CA
Click here to add this to my saved trials
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated:  12/31/1969
Florida Clinical Research Center, LLC
788
mi
from 43215
Orlando, FL
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated: 12/31/1969
Florida Clinical Research Center, LLC
788
mi
from 43215
Orlando, FL
Click here to add this to my saved trials
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated:  12/31/1969
FutureSearch Clinical Trials LP
1063
mi
from 43215
Austin, TX
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated: 12/31/1969
FutureSearch Clinical Trials LP
1063
mi
from 43215
Austin, TX
Click here to add this to my saved trials
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated:  12/31/1969
FutureSearch Clinical Trials, LP
905
mi
from 43215
Dallas, TX
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated: 12/31/1969
FutureSearch Clinical Trials, LP
905
mi
from 43215
Dallas, TX
Click here to add this to my saved trials
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated:  12/31/1969
J. Gary Booker, MD APMC
788
mi
from 43215
Shreveport, LA
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated: 12/31/1969
J. Gary Booker, MD APMC
788
mi
from 43215
Shreveport, LA
Click here to add this to my saved trials
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated:  12/31/1969
Lake Charles Clinical Trials LLC
884
mi
from 43215
Lake Charles, LA
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated: 12/31/1969
Lake Charles Clinical Trials LLC
884
mi
from 43215
Lake Charles, LA
Click here to add this to my saved trials
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated:  12/31/1969
Midwest Clinical Research Center
65
mi
from 43215
Dayton, OH
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated: 12/31/1969
Midwest Clinical Research Center
65
mi
from 43215
Dayton, OH
Click here to add this to my saved trials
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated:  12/31/1969
Neurobehavioral Research, Inc.
491
mi
from 43215
Cedarhurst, NY
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated: 12/31/1969
Neurobehavioral Research, Inc.
491
mi
from 43215
Cedarhurst, NY
Click here to add this to my saved trials
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated:  12/31/1969
New Hope Clinical Research
349
mi
from 43215
Charlotte, NC
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated: 12/31/1969
New Hope Clinical Research
349
mi
from 43215
Charlotte, NC
Click here to add this to my saved trials
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated:  12/31/1969
Oklahoma Clinical Research Center
mi
from 43215
Oklahoma City, OK
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated: 12/31/1969
Oklahoma Clinical Research Center
mi
from 43215
Oklahoma City, OK
Click here to add this to my saved trials
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated:  12/31/1969
Pacific Research Partners, LLC
2098
mi
from 43215
Oakland, CA
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated: 12/31/1969
Pacific Research Partners, LLC
2098
mi
from 43215
Oakland, CA
Click here to add this to my saved trials
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated:  12/31/1969
Pillar Clinic Research, LLC
903
mi
from 43215
Dallas, TX
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated: 12/31/1969
Pillar Clinic Research, LLC
903
mi
from 43215
Dallas, TX
Click here to add this to my saved trials
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated:  12/31/1969
Synergy Clinical Research of Escondido
1935
mi
from 43215
Escondido, CA
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated: 12/31/1969
Synergy Clinical Research of Escondido
1935
mi
from 43215
Escondido, CA
Click here to add this to my saved trials
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated:  12/31/1969
Via Christi Research
784
mi
from 43215
Wichita, KA
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated: 12/31/1969
Via Christi Research
784
mi
from 43215
Wichita, KA
Click here to add this to my saved trials